Skip to content

Evaluation of the efficacy and safety of thromboprophylaxis regimens in patients after the Fontan procedure

Evaluation of the efficacy and safety of thromboprophylaxis regimens in patients after the Fontan procedure - Evaluation of the efficacy and safety of thromboprophylaxis regimens in patients after the Fontan procedure

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000044127
Enrollment
3000
Registered
2021-05-07
Start date
2021-04-07
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients after the Fontan procedure

Interventions

None listed

Sponsors

Showa University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who underwent fontan procedure between June 2011 and September 2019 included in the data set from March 2011 to September 2020

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Onset of first thromboembolism for 1 year

Secondary

MeasureTime frame
Occurrence of bleeding events for 1 year

Countries

Japan

Contacts

Public ContactMasayuki Ohbayashi

Showa University Department of Pharmacotherapy, Department of Clinical Pharmacy,School of Pharmacy

ohbayashi@pharm.showa-u.ac.jp03-3784-8221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026